DOPATREE
DRUG SAFETY AND BIOLOGIC SAFETY (PHARMACOVIGILANCE, PV, CLINICAL, POSTMARKETING, SERIOUS ADVERSE EVENT, SAE, IND, 7-DAY, 15-DAY, EXPEDITED, SIDE EFFECTS, ICSR, PSUR, LITERATURE, SURVEILLANCE, E2B, SAFETY REPORTING, DATA, MEDICATION)
DRUG SAFETY AND BIOLOGIC SAFETY / RELATED / INTL
TREATMENT-RELATED CONDITIONS-ALL (DRUG-RELATED, BIOLOGIC-RELATED, DEVICE-RELATED, TREATMENT EMERGENT ADVERSE EVENTS, TEAE, ADVERSE DRUG REACTIONS, SIDE EFFECTS, ALL TOXICITIES, TOXICITY, PRODUCT-RELATED, DRUG-INDUCED)
TREATMENT-RELATED CONDITIONS / LISTINGS
PARASITIC INFECTIONS-ALL (PARASITES)
PARASITIC INFECTIONS / LISTINGS A-M
LEISHMANIASIS (KALA AZAR, KALA-AZAR, BLACK FEVER, DUMDUM FEVER, ESPUNDIA, VISCERAL LEISHMANIASIS, CUTANEOUS LEISHMANIASIS, MUCOSAL LEISHMANIASIS, SANDFLY-BORNE DISEASE, LEISHMANIA, L. DONOVANI, L. INFANTUM, L. CHAGASI, L. BRAZILIENSIS, L.. TROPICA)
LEISHMANIASIS / OVERVIEW

US CDC. LEISHMANIASIS. ACCESSED : MAY 2, 2022.

Attachments